Medicines in Oman’s market adhere to safety norms: MoH
The Ministry of Health (MoH) has reassured people of the quality and safety of medicines available in Oman.
The ministry released a statement to counter the allegations made on social media regarding availability of some medicines in the market which do not meet the standards and specifications laid down by the ministry.
The ministry stated that the National Pharmacovigilance Center at the Directorate General of Pharmaceutical Affairs and Drug Control undertakes the core responsibility of monitoring the quality, safety and efficacy of the drugs available in the sultanate.
‘The centre is committed further in following up on a daily basis all decisions related to medicine withdrawal and suspension that are issued by the various international and regional bodies and organisations.’
It added, ‘These decisions are put into analysis in order to take the necessary actions, taking into consideration the availability of the drugs in the local market and with the affected batch.’
The ministry further stated that some of the drug recall messages being circulated on social media are old. ‘The circulated drugs recall decisions of the manufacturer are not recent, dated nearly a year back (2019). A number of drugs were recalled locally either upon the Gulf decision or that our Central Drug Analysis Laboratory found the drugs unsuitable.’